In other study with 33 diabetes and 37 non-diabetes COVID-19 patients, those diabetes patients showed no differences in IgG, IgM, IgA, C3, and C4 complement proteins, and lymphocytes compared to non-diabetes patients. This evidence concerns the gene CD79A and diabetes mellitus.